Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

1 week ago 22
ARTICLE AD BOX

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.

Mike Blake | Reuters